10x Genomics, Inc. TXG Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s financing cash flow?
- 10x Genomics, Inc. (TXG) reported financing cash flow of -$8.42M in Q1 2026.
- How has 10x Genomics, Inc.'s financing cash flow changed year-over-year?
- 10x Genomics, Inc.'s financing cash flow decreased by 2094.5% year-over-year, from $422K to -$8.42M.
- What is the long-term trend for 10x Genomics, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s financing cash flow has grown at a -33.7% compound annual growth rate (CAGR), from $35.3M to $6.8M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.